Home DailyMed 9cf0f0cf-03db-4219-afe9-acf592024945 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:20:01 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A075356-001 PAROXETINE HYDROCHLORIDE PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 A075356-002 PAROXETINE HYDROCHLORIDE PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 A075356-003 PAROXETINE HYDROCHLORIDE PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 A075356-004 PAROXETINE HYDROCHLORIDE PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075356-001 PAROXETINE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2003-07-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075356-002 PAROXETINE HYDROCHLORIDE EQ 20MG BASE TABLET / ORAL AB 2003-07-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075356-003 PAROXETINE HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL AB 2003-07-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075356-004 PAROXETINE HYDROCHLORIDE EQ 40MG BASE TABLET / ORAL AB 2003-07-30 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 172 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.